Merck & Co., Inc. (MRK) stock analysis

MRK · Merck & Co., Inc.

Latest recorded price: USD 144.46

Model-estimated fair value: USD 91.24. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - General

At $144.46, MRK trades 58.3% above the model's base-case value of $91.24. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $70.16 in the conservative case and $114.93 in the optimistic case, with a valuation confidence score of 55/100. About 80% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 3.1%, free cash flow margin 19.0%, ROIC 17.2%. The model flags 1 risk signal for this company.

Similar companies in Healthcare